Top compounds associated with response to RASL12


Feature Type Standardized
Nominal ANOVA
mRNA barasertib CTRPv2 pan-cancer AAC -0.0012 1
mRNA GW843682X CTRPv2 pan-cancer AAC -0.0012 1
mRNA EX-527 GDSC1000 pan-cancer AAC -0.0011 1
mRNA Bortezomib GDSC1000 pan-cancer AAC 0.0015 1
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.0011 1
mRNA lenalidomide GDSC1000 pan-cancer AAC -0.001 1
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.00098 1
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.00097 1
mRNA PF-184 CTRPv2 pan-cancer AAC 0.0009 1
mRNA VX-702 GDSC1000 pan-cancer AAC 0.00092 1
Download CSV